Dr. Heyu Ni is the Platform Director for Hematology, Cancer and Immunological Diseases at Toronto’s St. Michael’s Hospital, a Senior Scientist at the Canadian Blood Services Centre for Innovation, and a professor at University of Toronto.

He is a world leader in the fields of thrombosis and haemostasis, conditions that lead to heart attack, stroke and bleeding disorders. He has discovered and redefined the mechanisms underlying these conditions and established the first intravital microscopy thrombosis model. His discovery of fibrinogen/VWF-independent thrombosis resulted in a paradigm shift in this field. He has also established several models of autoimmune/alloimmune diseases and tumor metastasis, and developed corresponding diagnostics and therapies. His discoveries have led to clinical trials in Canada, Norway, Denmark, Sweden, Netherlands, Australia and China.

Dr. Ni ranked #1 nationwide for fundamental research and #3 overall among all grant recipients from the Canadian Institutes of Health Research in 2018. Of his numerous publications, over 40 are in high impact journals, such as Nature Medicine and Science Translational Medicine. He has been on peer review committees for the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Natural Sciences and Engineering Research Council of Canada, National Institutes of Health (USA), Landsteiner Foundation for Blood Transfusion Research in Europe, and other prestigious foundations in Israel, Ireland, United Kingdom, Switzerland, and China. He has delivered 14 keynote and distinguished lectures and made presentations at 53 well-known institutions, including Harvard, MIT, Beijing Universities, Russian Academy of Sciences, Max Planck Institute, Sheba Medical Center, and INSERM.

2
1
3